Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02735239

Recruitment Status : Active, not recruiting

First Posted : April 12, 2016

Last Update Posted : February 18, 2021

Sponsor:

Collaborator:

AstraZeneca

Information provided by (Responsible Party):

Ludwig Institute for Cancer Research

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	November 2022
Estimated Study Completion Date :	March 2023

To Top